clinical_trials
Psilocybin Tied to Lower Inflammation in Parkinson's Trial
Confidence86·multiple reportsImportance88NP-EVT-20261021-F35306F
(MedPage Today) -- Markers of systemic inflammation and mitochondrial stress were reduced after psilocybin therapy in Parkinson's disease patients with mood dysfunction, a small nonrandomized trial showed. Relative to baseline, an inflammatory...
Read the original at the primary source
Psilocybin Tied to Lower Inflammation in Parkinson's Trial
10/21/2026, 9:00:23 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —